Assignee
NEXEL CO LTD
KR·3 granted patents·4 pending applications·1 citations·filing 2018–2024
Top patents by PatentIndex Score
7 records- 0165US2025115649A1Compositions and methods for treating or preventing fibrosisNEXEL CO LTD·Filed 2024·Application pending·0 cites
- 0259US11028139B2Recombinant protein for preventing or treating tissue fibrosis and composition for preventing or treating tissue fibrosis comprising the sameNEXEL CO LTD·Filed 2018·Granted Jun 8, 2021·1 cites·2 claims
- 0356US12139518B2Compositions and methods for treating or preventing fibrosisNEXEL CO LTD·Filed 2019·Granted Nov 12, 2024·0 cites·21 claims
- 0448US2025186545A1Recombinant protein for ulcerative colitis treatment or prevention and composition for ulcerative colitis treatment or prevention containing the sameNEXEL CO LTD·Filed 2022·Application pending·0 cites
- 0546US2023295576A1Method for producing human pluripotent stem cell-derived cardiac organoids and human pluripotent stem cell-derived cardiac organoids produced therebyNEXEL CO LTD·Filed 2022·Application pending·0 cites
- 0645US2024034751A1Polypeptide for preventing or treating idiopathic pulmonary fibrosis and pharmaceutical composition containing the sameNEXEL CO LTD·Filed 2022·Application pending·0 cites
- 0742US12571791B2Methods for evaluating cardiac safety of drug using cardiomyocytes derived from human stem cellsNEXEL CO LTD·Filed 2022·Granted Mar 10, 2026·0 cites·4 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →